Gold Pressed Latinum (CURRENCY:GPL) traded 2.2% lower against the dollar during the 1 day period ending at 17:00 PM E.T. on May 13th. In the last seven days, Gold Pressed Latinum has traded down 13.3% against the dollar. Gold Pressed Latinum has a total market cap of $67,024.00 and approximately
Listed on the Thai Stock Exchange and also traded over the US OTC markets via ADRs (OTCPK:BLJZY), Berli Jucker (BJC) is a leading integrated Thai retailer with operating presence across various countries in Southeast Asia.
Mid cap fabless semiconductor stock Marvell Technology Group Ltd (NASDAQ: MRVL) reported Q2 fiscal 2018 earnings after the Thursday market close with results beating Wall Street expectations. Q2 revenue was $604.750 million (which exceeded the midpoint of the Company’s guidance provided on May 25, 2017) versus $597.346 million. GAAP net income from continuing operations was $165.259 million....More>>>
"I remember when the Dow hit 1,000, and then 2,000," a friend in his 70s told me last month at lunch… "Now the Dow's near 20,000. That's scary." This friend is no dummy… He founded a major corporation that traded on the stock market. He had tens of thousands of employees. His net worth hit nine figures. And he's scared. I get that…....More>>>
September 30, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in Friday’s session.
Cognizant Technology Solutions Corp. (NASDAQ: CTSH) dropped more than 17% on Friday to post a new 52-week low of $45.44 after closing at $55.00 on Thursday. The stock’s 52-week high is $69.80. Volume was more than 10 times the daily average....More>>>
Equities analysts expect that Zynga (NASDAQ:ZNGA) will report earnings of $0.03 per share for the current quarter, according to Zacks. Five analysts have made estimates for Zynga’s earnings, with the lowest EPS estimate coming in at $0.02 and the highest estimate coming in at $0.03. Zynga posted earnings of $0.02 per share during the same quarter last year, which would suggest a positive year....More>>>
The headlines have been buzzing these past few days over reports that global tech giant Apple (NASDAQ:AAPL) might be considering moving some of its iPhone production from China to the US. The original report comes from a respectable Japanese publication, and at least on the surface seems somewhat logical in light of Donald Trump’s surprise win in the US presidential election.
Gene-based therapy is one of the next waves of therapeutic innovation to power this decade and far beyond. The FDA approvals regarding the RNA-based medicines of Sarepta Therapeutics (NASDAQ:SRPT) and the gene-therapy, Luxturna, of Spark Therapeutics (NASDAQ:ONCE) signaled the lowered r
The next-generation of cholesterol drugs -– compounds that inhibit PCSK-9 -– were approved in 2016; these targeted drugs rapidly reduce LDL cholesterol in a wide variety of patients with cardiovascular disease, notes Jay Silverman, editor of The Medical Technology Stock
With three product candidates in the pipeline, at a very early stage, Scholar Rock will need a long time to see the FDA approving them. That said, the company has many patents, a licence with Janssen Biotech, and a fantastic team of professionals. While the risk may be too high for the individua